Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
25.75
+0.02 (0.08%)
Dec 20, 2024, 4:00 PM EST - Market closed

Perrigo Company Revenue

Perrigo Company had revenue of $1.09B in the quarter ending September 28, 2024, a decrease of -3.23%. This brings the company's revenue in the last twelve months to $4.39B, down -5.63% year-over-year. In the year 2023, Perrigo Company had annual revenue of $4.66B with 4.58% growth.

Revenue (ttm)
$4.39B
Revenue Growth
-5.63%
P/S Ratio
0.80
Revenue / Employee
$480,525
Employees
9,140
Market Cap
3.51B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.66B204.00M4.58%
Dec 31, 20224.45B312.90M7.56%
Dec 31, 20214.14B50.50M1.24%
Dec 31, 20204.09B218.30M5.64%
Dec 31, 20193.87B-861.80M-18.21%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Jun 27, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Oscar Health 8.22B
DENTSPLY SIRONA 3.90B
Acadia Healthcare Company 3.12B
PTC Therapeutics 900.66M
NovoCure 577.74M
Alvotech 393.92M
CRISPR Therapeutics AG 202.83M
Rhythm Pharmaceuticals 112.53M
Revenue Rankings